4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-015419
Chief Medical Officer sold 16,500 shares at an average $18.52 ($305,610)
- Chief Medical Officer acquired 16,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raben David Chief Medical Officer | 2026-03-03 | Option exercise 10b5-1 | +200 | $3.79 | $758 | 55,486 | D |
| Raben David Chief Medical Officer | 2026-03-03 | Sale 10b5-1 | −200 | $18.45 | $3,690 | 55,286 | D |
| Raben David Chief Medical Officer | 2026-03-04 | Option exercise 10b5-1 | +16,300 | $3.79 | $61,774 | 71,586 | D |
| Raben David Chief Medical Officer | 2026-03-04 | Sale 10b5-1 | −16,300 | $18.52 | $301,920 | 55,286 | D |
| Derivatives | |||||||
| Raben David Chief Medical Officer | 2026-03-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200 | 69,213 | D | ||
| Raben David Chief Medical Officer | 2026-03-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,300 | 52,913 | D | ||
| Open-market sales · 16,500 sh · avg $18.52 · $305,610 | |||||||
Loading xslF345X05/wk-form4_1772755592.xml…